Published in Hepatogastroenterology on November 09, 2004
Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer. BMC Cancer (2006) 1.18
Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer. World J Surg (2012) 1.18
The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial. Br J Cancer (2010) 1.14
Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study. BMC Cancer (2014) 1.02
High plasma fibrinogen concentration and platelet count unfavorably impact survival in non-small cell lung cancer patients with brain metastases. Chin J Cancer (2013) 0.93
Preoperative plasma fibrinogen level is a useful predictor of adjacent organ involvement in patients with advanced gastric cancer. J Gastric Cancer (2012) 0.93
Molecular imaging of fibrin in a breast cancer xenograft mouse model. Invest Radiol (2012) 0.88
Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study. BMC Cancer (2016) 0.82
A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia. Biomark Res (2016) 0.75
Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis. J Gynecol Oncol (2017) 0.75
The pattern of polymorphism in Arabidopsis thaliana. PLoS Biol (2005) 10.13
An Arabidopsis example of association mapping in structured samples. PLoS Genet (2006) 7.03
Genome-wide association mapping in Arabidopsis identifies previously known flowering time and pathogen resistance genes. PLoS Genet (2005) 4.25
Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol (2011) 4.11
Association of family history with cancer recurrence and survival in patients with gastric cancer. J Clin Oncol (2012) 2.97
Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol (2004) 2.96
Salvage external beam radiotherapy for prostate cancer after radical prostatectomy: current status and controversy. Oncology (Williston Park) (2010) 2.01
Prognostic value of preoperative clinical staging assessed by computed tomography in resectable gastric cancer patients: a viewpoint in the era of preoperative treatment. Ann Surg (2010) 1.84
Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience. Ann Surg (2007) 1.74
The difficult choice between total and proximal gastrectomy in proximal early gastric cancer. Am J Surg (2008) 1.66
Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target. Oncol Rep (2011) 1.66
Endoscopic submucosal dissection for metachronous tumor in the remnant stomach after distal gastrectomy. Surg Endosc (2009) 1.63
Plasmon-enhanced ultraviolet photoluminescence from hybrid structures of graphene/ZnO films. Phys Rev Lett (2010) 1.56
Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. Gastroenterology (2010) 1.55
Oncologic effectiveness of regular follow-up to detect recurrence after curative resection of gastric cancer. Ann Surg Oncol (2010) 1.54
Developing an institutional protocol guideline for laparoscopy-assisted distal gastrectomy. Ann Surg Oncol (2009) 1.51
Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study. Gastrointest Endosc (2010) 1.51
Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees. Eur J Gastroenterol Hepatol (2009) 1.51
Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut (2013) 1.49
Gastric cancer patients at high-risk of having synchronous cancer. World J Gastroenterol (2006) 1.44
Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging (2005) 1.42
Technical feasibility and safety of laparoscopy-assisted total gastrectomy in gastric cancer: a comparative study with laparoscopy-assisted distal gastrectomy. J Surg Oncol (2009) 1.41
Optimal submucosal invasion of early gastric cancer for endoscopic resection. Ann Surg Oncol (2015) 1.39
Web-based tailored education program for disease-free cancer survivors with cancer-related fatigue: a randomized controlled trial. J Clin Oncol (2012) 1.34
Analysis of pacemaker activity in the human stomach. J Physiol (2011) 1.28
MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas. Mod Pathol (2013) 1.25
Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer. Ann Surg Oncol (2009) 1.23
Characteristics of synchronous cancers in gastric cancer patients. Cancer Res Treat (2006) 1.22
Hepatic splenosis diagnosed as hepatocellular carcinoma: report of a case. Surg Today (2002) 1.22
Long-term outcomes of laparoscopy-assisted distal gastrectomy for early gastric cancer: result of a randomized controlled trial (COACT 0301). Surg Endosc (2013) 1.22
Weekly irinotecan in patients with metastatic gastric cancer failing cisplatin-based chemotherapy. Jpn J Clin Oncol (2004) 1.22
Recurrence after curative resection of early gastric cancer. Ann Surg Oncol (2009) 1.19
Robot-assisted total gastrectomy is comparable with laparoscopically assisted total gastrectomy for early gastric cancer. Surg Endosc (2011) 1.16
Borrmann type IV: an independent prognostic factor for survival in gastric cancer. J Gastrointest Surg (2008) 1.14
Survival and surgical outcomes after laparoscopy-assisted total gastrectomy for gastric cancer: case-control study. Surg Endosc (2012) 1.12
The risk factors for lymph node metastasis in early gastric cancer patients who underwent endoscopic resection: is the minimal lymph node dissection applicable? A retrospective study. Surg Endosc (2013) 1.12
Glomus tumor of the stomach: a clinicopathologic analysis of 10 cases and review of the literature. Gut Liver (2012) 1.12
Changes of quality of life in gastric cancer patients after curative resection: a longitudinal cohort study in Korea. Ann Surg (2012) 1.11
Is the new seventh AJCC/UICC staging system appropriate for patients with gastric cancer? J Am Coll Surg (2011) 1.11
Sentinel node mapping and skip metastases in patients with early gastric cancer. Ann Surg Oncol (2009) 1.11
Learning curve for total gastrectomy with D2 lymph node dissection: cumulative sum analysis for qualified surgery. Ann Surg Oncol (2006) 1.10
Association of the interval between endoscopies with gastric cancer stage at diagnosis in a region of high prevalence. Cancer (2012) 1.07
Feasibility of laparoscopic sentinel basin dissection for limited resection in early gastric cancer. J Surg Oncol (2008) 1.06
Laparoscopic "Dome-down" cholecystectomy with the LCS-5 Harmonic scalpel. JSLS (2005) 1.06
Health-related quality of life among disease-free stomach cancer survivors in Korea. Qual Life Res (2006) 1.06
Multicenter Prospective Comparative Study of Robotic Versus Laparoscopic Gastrectomy for Gastric Adenocarcinoma. Ann Surg (2016) 1.05
Development of oncolytic adenovirus armed with a fusion of soluble transforming growth factor-beta receptor II and human immunoglobulin Fc for breast cancer therapy. Hum Gene Ther (2006) 1.05
Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement. Cancer Chemother Pharmacol (2010) 1.04
The association between Helicobacter pylori status and incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer. Helicobacter (2014) 1.04
Nutritional risk index as a predictor of postoperative wound complications after gastrectomy. World J Gastroenterol (2012) 1.03
Gastroenteropancreatic neuroendocrine tumors: incidence and treatment outcome in a single institution in Korea. Asia Pac J Clin Oncol (2011) 1.02
Proposal to subclassify stage IV gastric cancer into IVA, IVB, and IVM. Arch Surg (2009) 1.02
Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy. Ann Surg (2008) 1.01
Micropapillary carcinoma of stomach: a clinicopathologic and immunohistochemical study of 11 cases. Am J Surg Pathol (2010) 1.01
Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer. Cancer (2008) 1.00
Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas. Mod Pathol (2012) 1.00
Phase 3 trial of postoperative chemotherapy alone versus chemoradiation therapy in stage III-IV gastric cancer treated with R0 gastrectomy and D2 lymph node dissection. Int J Radiat Oncol Biol Phys (2012) 1.00
Circulating numbers of endothelial progenitor cells in patients with gastric and breast cancer. Cancer Lett (2003) 0.99
A phase-II clinical trial of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for gastric cancer patients. Ann Surg Oncol (2007) 0.99
Gastric cancer staging at isotropic MDCT including coronal and sagittal MPR images: endoscopically diagnosed early vs. advanced gastric cancer. Abdom Imaging (2009) 0.99
Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer. Int J Cancer (2010) 0.98
Predictors of timing and patterns of recurrence after curative resection for gastric cancer. Dig Surg (2010) 0.98
Inhibition of lipopolysaccharide-induced nitric oxide synthesis by nicotine through S6K1-p42/44 MAPK pathway and STAT3 (Ser 727) phosphorylation in Raw 264.7 cells. Cytokine (2008) 0.97
Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy. Clin Cancer Res (2008) 0.97
Effects of interleukin-10 polymorphisms, Helicobacter pylori infection, and smoking on the risk of noncardia gastric cancer. PLoS One (2012) 0.97
Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma. APMIS (2009) 0.97
The influence of reconstruction methods on food retention phenomenon in the remnant stomach after a subtotal gastrectomy. J Surg Oncol (2008) 0.96
A new suggestion for the radiation target volume after a subtotal gastrectomy in patients with stomach cancer. Int J Radiat Oncol Biol Phys (2008) 0.96
The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy. J Surg Oncol (2011) 0.95
Comparison of four immunohistochemical tests and FISH for measuring HER2 expression in gastric carcinomas. Pathology (2012) 0.95
Mucinous gastric cancer presents with more advanced tumor stage and weaker β-catenin expression than nonmucinous cancer. Ann Surg Oncol (2010) 0.95
Surgical outcome of synchronous second primary cancer in patients with gastric cancer. Yonsei Med J (2007) 0.95
General perioperative management of gastric cancer patients at high-volume centers. Gastric Cancer (2011) 0.94
Abdominal shape of gastric cancer patients influences short-term surgical outcomes. Ann Surg Oncol (2007) 0.94
Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer. Pharmacogenomics (2009) 0.94
Factors associated with detection failure and false-negative sentinel node biopsy findings in gastric cancer: results of prospective single center trials. J Surg Oncol (2009) 0.93
Preoperative plasma fibrinogen level is a useful predictor of adjacent organ involvement in patients with advanced gastric cancer. J Gastric Cancer (2012) 0.93
Sentinel node biopsy using dye and isotope double tracers in early gastric cancer. Ann Surg Oncol (2006) 0.93
3D meshless prostate segmentation and registration in image guided radiotherapy. Med Image Comput Comput Assist Interv (2009) 0.93
HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy. Int J Cancer (2014) 0.93
Laparoscopy-assisted distal gastrectomy in a patient with early gastric cancer and polysplenia. Surg Laparosc Endosc Percutan Tech (2012) 0.93
A Risk-prediction Model Based on Lymph-node Metastasis for Incorporation Into a Treatment Algorithm for Signet Ring Cell-type Intramucosal Gastric Cancer. Ann Surg (2016) 0.92
Regional differences of the effects of acetylcholine in the human gastric circular muscle. Am J Physiol Gastrointest Liver Physiol (2010) 0.92
Weekly docetaxel in combination with capecitabine in patients with metastatic gastric cancer. Am J Clin Oncol (2005) 0.92